FindMyKOL

Valerie Barta, MD

Basic profile

Lenox Hill Hospital

ORCIDNone on fileNPIOn fileSign in to see identifiers
✓ Itemized record
RegionNew York, NY · NortheastSpecialtyNephrologyFocusNephrology
Active KOLFindMyKOL type: RegionalLatest publication2021Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Valerie Barta is a Nephrology physician affiliated with Lenox Hill Hospital. OpenAlex indexes 11 publications with 15,494 citations (h-index 6). By OpenAlex citation count, this profile ranks in the top 10% of Nephrology profiles in the FindMyKOL directory.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
11publications

Publications indexed by OpenAlex. Counts exclude supporting files.

15,494citations

Citations across these publications.

6h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
7companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Industry payments

7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

  • Amgen Inc.
    Program year20251 payment
    $25
  • Bayer Healthcare Pharmaceuticals Inc.
    Program year20241 payment
    $24
  • Amgen Inc.
    Program year20241 payment
    $21
All 8 payment records: search, sort and filter.Explore →

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    58.3%
    Beta blocker18.5%
    Carvedilol100%
    Part D<11 patients
    Calcium channel blocker15.9%
    Amlodipine Besylate100%
    Part D<11 patients

    + 2 more classes in this area

  • Metabolism & gastrointestinal

    29.1%
    SGLT2 inhibitor17.9%
    Farxiga100%
    Part D<11 patients
    Vitamin D3 Analog11.3%
    Calcitriol100%
    Part D<11 patients
  • Other

    12.6%
    Drugs for treatment of hyperkalemia and hyperphosphatemia12.6%
    Lokelma100%
    Part D<11 patients
Where care is delivered (Part B)62.2% facility · 37.8% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”